![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, May 18, 2010 4:47:34 PM
As for the rest of you - you have to ask yourself, "will U.S. sales for these two drugs help them achieve $531 mln in EBITDA in the next 3 qtrs.?"
I don't know.
The ultimate goal is 1.267 Bln spread out over 3 years. They're $531 mln away from making that goal. It took them 9 qtrs. to make $736,000,000. So, bearing in mind that they can count the U.S. sales of these two pretty big cancer drugs towards their EBITDA, plus you have this (which went virtually unnoticed earlier this month...
http://www.avma.org/onlnews/javma/may10/...
So they've been making on average about $81 mln a qtr for the last 9 qtrs. Can they now expect to report adjusted EBITDA of $177 mln a qtr for the next 3 qtrs.?
THAT is the 980 million dollar question.
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM